Healthcare Services Group Inc (HCSG) Return on Investment ROI from the second quarter of 2026 to second quarter of 2025 and for the year 2026, average high and low, overall ranking from Jun 30 2026 to Jun 30 2025 - CSIMarket
CSIMarket
 


Healthcare Services Group Inc   (NASDAQ: HCSG)
    Sector • Healthcare    Industry • Healthcare Facilities
   Industry • Healthcare Facilities
   Sector • Healthcare


Healthcare Services Group Inc's ROI from its second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Healthcare Services Group Inc's ROI in the second quarter of 2026?
Healthcare Services Group Inc achieved a return on average invested assets (ROI) of 21.22 % in its second quarter of 2026, this is above HCSG's average return on investment of 12.85%.
Healthcare Services Group Inc invested over the 12 months ending in its second quarter of 2026 $579 million

Despite the deterioration in its net income, company has improved ROI compared to the first quarter of 2026.

Within the Healthcare sector 49 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the first quarter of 2026 from 553 to 663.

Definition and Formula of Return on Investment



Return On Investment (Jun 30 2026)
II. Quarter
(Mar 31 2026)
I. Quarter
(Dec 31 2025)
IV. Quarter
(Sep 30 2025)
III. Quarter
(Jun 30 2025)
II. Quarter
Y / Y Investment Change TTM 6.44 % 2.19 % 3.94 % 5.76 % 8.65 %
Y / Y Net Income Change TTM 1037.19 % 64.03 % 144.43 % 224.58 % -
Investment (TTM) in Millions 633 567 566 552 529
Return On Investment (TTM) 21.22 % 12.27 % 10.7 % 7.25 % 1.99 %
HCSG's Overall Ranking # 663 # 553 # 563 # 426 # 1468
Seq. Investment Change TTM 4.7 % 0.26 % 0.76 % 0.64 % 0.51 %
Seq. Net Income Change TTM 81.1 % 14.95 % 48.63 % 267.51 % -73.88 %
Net Income (TTM) in Millions 123 68 59 40 11




Return On Investment HCSG's Ranking
Within: No.
Industry # 1
Sector # 50
Overall # 663

Return On Investment Statistics
High Average Low
20.93 %
12.85 %
1.96 %
(Jun 30 2026)   (Jun 30 2025)







Financial Statements
Healthcare Services Group Inc's II. Quarter Investments $ 633 Millions HCSG's Balance sheet
Healthcare Services Group Inc's II. Quarter Income $ 23 Millions Quarterly HCSG's Income Statement
HCSG's Income by Division See HCSG's Income by Division


HCSG Annual Return On Investment (Dec 31 2025)
2025
(Dec 31 2024)
2024
(Dec 31 2023)
2023
(Dec 31 2022)
2022
(Dec 31 2021)
2021
Total Investments in Millions 566 550 498 460 575
Y / Y Investment Growth 3.01 % 10.47 % 8.23 % -20.03 % -7.65 %
Net Income in Millions 59 39 38 35 46
Y / Y Net Income Growth 49.63 % 2.83 % 10.85 % -24.49 % -53.52 %
Annual Return On Investment 10.43 % 7.18 % 7.71 % 7.53 % 7.97 %


Annual Roi Comment
In the fiscal year 2025 ROI improved to 10.43 % compared to the prior year, due to net income growth.

Definition and Formula of Return on Investment

Other ROI Ratios
Healthcare Facilities Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
HCSG's Roi Ratio versus Healthcare Facilities Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for HCSG's Competitors
Subscribers only: Roi for Healthcare Services Group Inc's Suppliers
Subscribers only: Return On Investment for HCSG's Customers

Other Ratios
HCSG's Roa HCSG's Inventory Turnover Ratio HCSG's Growth Rates HCSG's Dividend Statistics
HCSG's Profitability Ratios HCSG's Asset Turnover Ratio HCSG's Dividend Growth
HCSG's Roe HCSG's Valuation Ratios HCSG's Financial Strength Ratios HCSG's Dividend Payout Ratio



Companies with similar Return On Investment at Jun 30 2026, within Healthcare Sector ROI
Meiragtx Holdings Plc  55.83 %
Elite Pharmaceuticals Inc   53.48 %
Idexx Laboratories Inc  51.80 %
Aurinia Pharmaceuticals Inc   50.35 %
Qhslab Inc   48.94 %
Q32 Bio Inc   47.43 %
Vaxart Inc   46.17 %
Liquidia Corporation  42.09 %
Tg Therapeutics Inc   39.26 %
Medpace Holdings Inc   35.54 %
Mettler toledo International Inc   34.41 %
Eli Lilly And Company  33.95 %
Acadia Pharmaceuticals Inc   31.05 %
Caredx Inc   29.42 %
Adma Biologics Inc   28.94 %
Protalix Biotherapeutics inc   25.72 %
Pro dex Inc   24.29 %
Innoviva Inc   23.33 %
Electromed Inc   23.18 %
Zevra Therapeutics Inc   22.90 %
Iradimed Corporation  22.57 %
Alnylam Pharmaceuticals Inc   22.10 %
Eton Pharmaceuticals Inc   21.31 %
Dexcom Inc   20.98 %
Healthcare Services Group Inc   20.93 %
Arcutis Biotherapeutics Inc   20.77 %
Chemed Corporation  20.13 %
Resmed Inc   20.01 %
Halozyme Therapeutics Inc   19.99 %
Vertex Pharmaceuticals Inc  19.97 %


Date modified: 2026-09-20T03:42:28+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.